Patent Term Extended Under 35 U.S.C. 156(d)(5) An order granting a one-year interim extension of the term of the following patent was granted on April 7, 1997. U.S. Patent No. 4,197,297; Granted June 13, 1989, to Joseph Weinstock; Owner of Record: SmithKline Beecham Corporation; Title: 6-Halo-7,8-Dihy- droxy-1-(Hydroxyphenyl)-2,3,4,5-Tetrahydro-1H-3-Benzazepines; Classifica- tion: 514/213; Product Name: CORLOPAM ; Active Ingredient: Fenoldopam Mesylate; Original Expiration Date: April 8, 1997; Term Extended: One Year; Extended Expiration Date: April 8, 1998. Patent Term Extended Under 35 U.S.C. 156 A certificate extending the term of the following patent was issued on April 4, 1997. U.S. Patent No. 4,839,342; Granted June 13, 1989, to Renee Kaswan; Owner of Record: University of Georgia Research Foundation, Inc.; Title: Method of Increasing Tear Production by Topical Administration of Cyclosporin; Classification: 514/256; Product Trade Name: OPTIMMUNE ; Original Expiration Date: September 2, 2007; Term Extended: 700 days; Extended Expiration Date: August 2, 2009.